---
figid: PMC9221461__cancers-14-02845-g004
pmcid: PMC9221461
image_filename: cancers-14-02845-g004.jpg
figure_link: /pmc/articles/PMC9221461/figure/cancers-14-02845-f004/
number: Figure 4
figure_title: ''
caption: The risk score predicts the sensitivity of the TCGA-LUAD patients to chemotherapy.
  Predicted response to drugs, including cisplatin (a), docetaxel (b), gemcitabine
  (c), and paclitaxel (d).
article_title: LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer
  by Inactivating the STAT3 Pathway.
citation: Jianqun Ma, et al. Cancers (Basel). 2022 Jun;14(12):2845.
year: '2022'

doi: 10.3390/cancers14122845
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- lncRNA HAR1A
- STAT3
- proliferation
- prognostic signature
- LUAD

---
